The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Feasibility of molecular patient selection in rare cancers: Phase II study of gemcitabine, oxaliplatin and capecitabine in KRAS mutated biliary tract cancer.
 
Lars Henrik Jensen
Honoraria - AstraZeneca
Travel, Accommodations, Expenses - Amgen; Bayer; Roche
 
Eva Fernebro
No Relationships to Disclose
 
John Ploen
No Relationships to Disclose
 
Jan Lindebjerg
No Relationships to Disclose
 
Anders Kristian Moeller Jakobsen
No Relationships to Disclose